LWM
IDXX icon

Lyell Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Lyell Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
22,660
+143
+0.6% +$80.2K 0.73% 44
2026
Q1 		$12.7M Sell
22,517
-796
-3% -$510K 0.93% 33
2025
Q4 		$15.8M Buy
23,313
+136
+0.6% +$92.6K 1.14% 31
2025
Q3 		$14.8M Buy
23,177
+35
+0.2% +$21.2K 1.1% 32
2025
Q2 		$12.4M Buy
23,142
+677
+3% +$324K 0.98% 35
2025
Q1 		$9.43M Buy
22,465
+1,342
+6% +$583K 0.88% 37
2024
Q4 		$8.73M Buy
21,123
+72
+0.3% +$31.6K 0.78% 43
2024
Q3 		$10.6M Sell
21,051
-88
-0.4% -$42.8K 0.97% 32
2024
Q2 		$10.3M Buy
21,139
+868
+4% +$436K 0.98% 35
2024
Q1 		$10.9M Buy
20,271
+291
+1% +$159K 1.11% 28
2023
Q4 		$11.1M Buy
19,980
+550
+3% +$258K 1.26% 23
2023
Q3 		$8.5M Buy
19,430
+19
+0.1% +$9.47K 1.14% 32
2023
Q2 		$9.75M Buy
19,411
+247
+1% +$118K 1.25% 26
2023
Q1 		$9.58M Sell
19,164
-603
-3% -$289K 1.34% 22
2022
Q4 		$8.06M Sell
19,767
-62
-0.3% -$24.1K 1.27% 26
2022
Q3 		$6.46M Sell
19,829
-44
-0.2% -$16.2K 1.1% 31
2022
Q2 		$6.97M Sell
19,873
-436
-2% -$178K 1.14% 28
2022
Q1 		$11.1M Sell
20,309
-679
-3% -$357K 1.43% 21
2021
Q4 		$13.8M Buy
20,988
+1,030
+5% +$647K 1.58% 19
2021
Q3 		$12.4M Buy
19,958
+49
+0.2% +$32.9K 1.51% 23
2021
Q2 		$12.6M Buy
19,909
+457
+2% +$252K 1.56% 20
2021
Q1 		$9.52M Sell
19,452
-111
-0.6% -$55.6K 1.39% 26
2020
Q4 		$9.78M Sell
19,563
-9
-0% -$4.03K 1.56% 23
2020
Q3 		$7.69M Buy
19,572
+115
+0.6% +$42.5K 1.44% 25
2020
Q2 		$6.42M Buy
19,457
+825
+4% +$239K 1.41% 28
2020
Q1 		$4.51M Buy
18,632
+1,202
+7% +$314K 1.35% 34
2019
Q4 		$4.55M Buy
17,430
+1,636
+10% +$431K 1.22% 37
2019
Q3 		$4.29M Buy
15,794
+671
+4% +$187K 1.29% 37
2019
Q2 		$4.16M Buy
+15,123
New +$3.73M 1.26% 34

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Lyell Wealth Management's IDXX Position: Q2 2026 in Review

Lyell Wealth Management increased its Idexx Laboratories (IDXX) stake by 0.64% in Q2 2026, buying an estimated $80.2K and bringing the position to 22,660 shares worth $11.9M. The position accounts for 0.73% of the portfolio, ranked #44.

Lyell Wealth Management first reported a position in IDXX in Q2 2019 and has held it in 29 quarters since. The position peaked at $15.8M in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Lyell Wealth Management held 22,660 shares of Idexx Laboratories worth $11.9M as of Q2 2026.
  • Lyell Wealth Management bought 143 Idexx Laboratories shares in Q2 2026, an estimated $80.2K.
  • Idexx Laboratories made up 0.73% of Lyell Wealth Management's portfolio in Q2 2026, its #44 holding.
  • Lyell Wealth Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 29 quarters since.
  • Lyell Wealth Management's Idexx Laboratories position peaked at $15.8M in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Lyell Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.